EQUAL! Request for Proper Medical Care for Transsexual Employees In the spirit of openness and fairness to all Lucent employees that has recently been expressed by the much appreciated inclusion of "gender identity, characteristics, or expression" in our EO nondiscrimination policy, we request that Lucent remove the discriminatory exclusion of "sex reassignment and treatment leading to it" from our medical plans, thus extending proper medical coverage to its transsexual employees. This offering would mean full and equal coverage for their medical needs, and would cost Lucent almost nothing. Transsexual employees are those employees who require a procedure called Sex Reassignment Surgery (SRS) in order to live a normal life. These people were born with the body of one sex, but a firmly held internal gender identity of the opposite sex. Both male-to-female (MtF) and female-to-male (FtM) transsexuals exist, and both require treatment. Many transsexuals are suicidal unless they are properly treated. The medical community has long ago adopted a standard diagnosis ("Gender Identity Disorder") and treatment for transsexuals, governed by a formal standard called the Harry Benjamin Standards of Care (SOC.) The SOC are designed very conservatively, to ensure that only true transsexuals are considered for medical intervention. Many individuals who believe they might be transsexuals are screened out by the SOC. Only those who truly require SRS in order to live a normal life are approved for treatment. In addition, a series of careful steps is taken, over a period of at least a full year (and usually several years) to ensure that the individual is a true transsexual, and that he or she adjusts well to the new role. SRS is often on the list of exclusions in medical plans. Lucent's medical plan is no exception, as it excludes SRS and other required treatments (generally, hormone replacement therapy (HRT), the same treatment often used for the treatment of menopause.) There is no medical reason for this exclusion, but rather the exclusion is rooted in the bigotry of the past. Lucent, as a forward looking company committed to equal treatment of employees, cannot afford to prepetuate such bigotry. Only about 1 in 30,000 individuals is transsexual. For a company the size of Lucent, we can expect that we have about 4 transsexual employees. Indeed, according to the Summary Annual Benefits sent to employees in December, 1999, in plan year 1998, there were 112,201 people covered by our Management and Occupational health plans. There are currently 4 known transsexuals in Lucent at various stages of the transition process. The lifetime medical cost for SRS, HRT, and related care averages only about $25,000 per transsexual. If the average employment is estimated at 5 years, and four transsexuals are somewhere in the process at any given time, Lucent would spend a total of about $20,000 per year. Lucent spent $446,311,000 in 1998 on medical care. Providing medical coverage to our four transsexuals would increase our total expendatures to $446,331,000. This amount is about 18 cents per year for each covered person, or an increase of .00448%. It is less than 10% of the investment income our insurance plan earns. Two objections that have been raised in the past are that SRS is experimental, or that it is cosmetic, or that it is a choice. None of these is true. The first SRS was performed in 1952 on Christine Jorgenson. In the years that followed, the technique was refined and perfected. SRS is now routine, widely taught, and available from many surgeons in the US and abroad. It has not been experimental for many years. SRS is also not cosmetic. Indeed, successful completion of surgery is required in order to change certain legal documents, such as the birth certificate, and drivers license, that will allow basic human rights like marriage and the safe and legal use of public restrooms. Jessica Xavier, a transgendered woman, explains what the desire to start the transition process is like: "It becomes this force that builds in you and you can't live without it anymore. Most of us look at it as life and death. After all, if it were a choice, who would choose to face universal disapproval and discrimination?" Lucent Technologies contracts with several health care providers, such as CIGNA, for MEP and POS medical plans. The companies suggest a "standard" set of coverages and exclusions to Lucent. Lucent then specifies what coverages and exclusions it is willing to pay for, and those become the contracted conditions. We urge Lucent to require our MEP and POS medical providers to delete transsexualism and its associated procedures and medications from their exclusion list, and to cover this basic and often lifesaving care for its employees. Respectfully, The leadership of EQUAL! at Lucent Technologies